Table 1.
Baseline characteristics of study population (Fisse el al., under review)
| All patients (n = 29) | |
|---|---|
| Demographics | |
| Age in years, mean (SD) | 65 (12) |
| Women, n (%) | 10 (35) |
| Body mass index, mean (SD) | 25 (5) |
| Disease characteristics | |
| Disease duration until inclusion in days, median (IQR) | 6 (8) |
| Days of sedation, median (IQR) | 12 (15) |
| Days of vasopressor-use, median (IQR) | 8 (13) |
| mRS at inclusion, median (IQR) | 5 (0) |
| GCS at inclusion, median (IQR) | 3 (2) |
| SOFA at inclusion, median (IQR) | 9 (4) |
| Maximum SOFA during ICU stay, median (IQR) | 10 (3) |
| Sepsis, n (%) | 13 (45) |
| Reanimation, n (%) | 13 (45) |
| Stroke or intracranial hemorrhage, n (%) | 8 (28) |
| Any primary CNS disease, n (%) | 19 (66) |
| Follow up time in days, median (IQR) | 26 (46) |
| Laboratory values at inclusion, mean (SD) | |
| Leukocytes in 1000/µl | 10.9 (4.7) |
| Thrombocytes in 1000/µl | 250 (142) |
| Haemoglobin in g/dl | 10.4 (2.6) |
| Creatine kinase in U/l | 1048 (2359) |
| Procalcitonin in ng/ml | 1.9 (5.0) |
| Glucose in mg/dl | 156 (75) |
| C-reaktive protein in mg/l | 122 (101) |
| Creatinine in mg/dl | 1.1 (0.8) |
| Bilirubin in mg/dl | 0.7 (0.8) |
| Oxygen partial pressure (paO2) in mmHg | 109 (35) |
Mrs modified Rankin Scale, GCS Glasgow coma scale, SOFA sepsis-related organ failure assessment score, ICU intensive care unit, CNS central nervous system